Skip to main content
Log in

Ist die generelle Streichung von Sulfonamiden in der externen Therapie gerechtfertigt?

  • Berichte und Briefe
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Aufbereitungsmonographie Sulfamerazin, Kommission B 6, BAnz.Nr. 41 vom 28.2.1990, S 988

  2. Höger PH (1998) Topische Antibiotika und Antiseptika. Hautarzt 49:331–347

    Article  PubMed  Google Scholar 

  3. Simon C, Stille W (1993) Lokalantibiotika. In: Simon C, Stille W (Hrsg) Antibiotika-Therapie in Klinik und Praxis, 8.Aufl. Schattauer, Stuttgart, S 207–213

    Google Scholar 

  4. McKenna SR, Latenser BA, Jones LM, Parette RR, Sherman HF, Varcelotti JR (1995) Serious silver sulfadiazine and mafenide acetate dermatitis. Burns 21:310–312

    Article  CAS  PubMed  Google Scholar 

  5. Yaffee HS, Dressler DP (1969) Topical application of mafenide acetate: Its association with erythema multiforme and cutaneous reactions. Arch Dermatol 100:277–281

    Article  Google Scholar 

  6. Fischer H, Reimann H (2000) Sulfonamide nicht auf die Haut. Pharm Ztg 145:2304

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heise, H., Box, A. Ist die generelle Streichung von Sulfonamiden in der externen Therapie gerechtfertigt?. Hautarzt 53, 225–226 (2002). https://doi.org/10.1007/s00105-001-0330-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-001-0330-8

Navigation